Lipid lowering: another method of reducing blood pressure?
Open Access
- 1 November 2002
- journal article
- review article
- Published by Springer Science and Business Media LLC in Journal of Human Hypertension
- Vol. 16 (11), 753-760
- https://doi.org/10.1038/sj.jhh.1001483
Abstract
Modern management of cardiovascular risk depends on assessment of cardiovascular risk factors. Hypertension and hyperlipidaemia are synergistic risk factors for cardiovascular events. Both show a degree of cross-correlation through sharing mechanisms of pathogenesis including insulin resistance and endothelial dysfunction. This article reviews the common pathways leading to dyslipidaemia and hypertension and the effects diet and lipid-lowering drug therapies have had on correcting blood pressure in patients with essential hypertension. Both statins and fibrates have shown a capability to lower blood pressure by up to 8/5 and 15/10 mmHg respectively, in some small-scale clinical trials and have effects on arterial wall structure and hence pulse wave velocity. This blood pressure action may account for some of the clinical effects of lipid-lowering drugs on cardiovascular risk. Thus, lipid lowering may provide an additional method of correcting hypertension in some high-risk patients. However, data from large-scale intervention trials are either absent or ambiguous. Definitive large-scale trials to investigate the antihypertensive effects of lipid-lowering drugs are required, although end point studies examining the interaction of lipid-lowering and antihypertensive drugs to determine optimum combinations are already under way.Keywords
This publication has 69 references indexed in Scilit:
- Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trialThe Lancet, 1999
- Mediterranean Diet, Traditional Risk Factors, and the Rate of Cardiovascular Complications After Myocardial InfarctionCirculation, 1999
- Hypertension, dyslipidemia, and insulin resistance: links in a chain or spokes on a wheel?Current Opinion in Lipidology, 1996
- Hyperlipidaemia, hypertension, and coronary heart diseaseThe Lancet, 1995
- By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?BMJ, 1994
- The epidemiology of impaired glucose tolerance and hypertensionAmerican Heart Journal, 1991
- Association between blood pressure and serum lipids in a population. The Tromsø Study.Circulation, 1991
- A population at risk: Prevalence of high cholesterol levels in hypertensive patients in the framingham studyAmerican Journal Of Medicine, 1986
- Clustering of cardiovascular disease risk factorsPreventive Medicine, 1980
- Coronary risk factors in a community. Findings in Tecumseh, Michigan.Circulation, 1976